144 related articles for article (PubMed ID: 24055188)
1. Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines.
Amiri F; Zarnani AH; Zand H; Koohdani F; Jeddi-Tehrani M; Vafa M
Eur J Pharmacol; 2013 Oct; 718(1-3):34-40. PubMed ID: 24055188
[TBL] [Abstract][Full Text] [Related]
2. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
Mahyar-Roemer M; Roemer K
Oncogene; 2001 Jun; 20(26):3387-98. PubMed ID: 11423989
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53.
Hsieh TC; Wang Z; Hamby CV; Wu JM
Biochem Biophys Res Commun; 2005 Aug; 334(1):223-30. PubMed ID: 15993843
[TBL] [Abstract][Full Text] [Related]
4. Role of p21 as a determinant of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl] diamantane response in human HCT-116 colon carcinoma cells.
Wang JJ; Hung HF; Huang ML; Lee HJ; Chern YT; Chang YF; Chi CW; Hsu YC
Oncol Rep; 2012 Feb; 27(2):529-34. PubMed ID: 22076474
[TBL] [Abstract][Full Text] [Related]
5. Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil.
Fricke E; Hermannstädter C; Keller G; Fuchs M; Brunner I; Busch R; Höfler H; Becker KF; Luber B
Oncology; 2004; 66(2):150-9. PubMed ID: 15138368
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines.
Cosse JP; Sermeus A; Vannuvel K; Ninane N; Raes M; Michiels C
Mol Cancer; 2007 Sep; 6():61. PubMed ID: 17894897
[TBL] [Abstract][Full Text] [Related]
7. IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line.
Vucenik I; Tantivejkul K; Zhang ZS; Cole KE; Saied I; Shamsuddin AM
Anticancer Res; 1998; 18(6A):4083-90. PubMed ID: 9891449
[TBL] [Abstract][Full Text] [Related]
8. Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells.
Lin H; Xiong W; Zhang X; Liu B; Zhang W; Zhang Y; Cheng J; Huang H
Oncol Rep; 2011 Oct; 26(4):925-30. PubMed ID: 21743969
[TBL] [Abstract][Full Text] [Related]
9. Functional proteomics of resveratrol-induced colon cancer cell apoptosis: caspase-6-mediated cleavage of lamin A is a major signaling loop.
Lee SC; Chan J; Clement MV; Pervaiz S
Proteomics; 2006 Apr; 6(8):2386-94. PubMed ID: 16518869
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis induced by capsaicin and resveratrol in colon carcinoma cells requires nitric oxide production and caspase activation.
Kim MY; Trudel LJ; Wogan GN
Anticancer Res; 2009 Oct; 29(10):3733-40. PubMed ID: 19846903
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1.
Li Y; Zhu W; Li J; Liu M; Wei M
Oncol Rep; 2013 Dec; 30(6):2820-8. PubMed ID: 24064760
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol-induced p53-independent apoptosis of human nasopharyngeal carcinoma cells is correlated with the downregulation of ΔNp63.
Chow SE; Wang JS; Chuang SF; Chang YL; Chu WK; Chen WS; Chen YW
Cancer Gene Ther; 2010 Dec; 17(12):872-82. PubMed ID: 20725098
[TBL] [Abstract][Full Text] [Related]
13. Structural modification of resveratrol leads to increased anti-tumor activity, but causes profound changes in the mode of action.
Scherzberg MC; Kiehl A; Zivkovic A; Stark H; Stein J; Fürst R; Steinhilber D; Ulrich-Rückert S
Toxicol Appl Pharmacol; 2015 Aug; 287(1):67-76. PubMed ID: 26044878
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells.
Yu H; Pan C; Zhao S; Wang Z; Zhang H; Wu W
Biomed Pharmacother; 2008; 62(6):366-72. PubMed ID: 17988825
[TBL] [Abstract][Full Text] [Related]
15. Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells.
Du Q; Hu B; An HM; Shen KP; Xu L; Deng S; Wei MM
Oncol Rep; 2013 May; 29(5):1851-8. PubMed ID: 23446753
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line.
Saied IT; Shamsuddin AM
Anticancer Res; 1998; 18(3A):1479-84. PubMed ID: 9673359
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol induces cell cycle arrest via a p53-independent pathway in A549 cells.
Yuan L; Zhang Y; Xia J; Liu B; Zhang Q; Liu J; Luo L; Peng Z; Song Z; Zhu R
Mol Med Rep; 2015 Apr; 11(4):2459-64. PubMed ID: 25515619
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol contributes to chemosensitivity of malignant mesothelioma cells with activation of p53.
Lee YJ; Park IS; Lee YJ; Shim JH; Cho MK; Nam HS; Park JW; Oh MH; Lee SH
Food Chem Toxicol; 2014 Jan; 63():153-60. PubMed ID: 24239893
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol induces DNA damage in colon cancer cells by poisoning topoisomerase II and activates the ATM kinase to trigger p53-dependent apoptosis.
Demoulin B; Hermant M; Castrogiovanni C; Staudt C; Dumont P
Toxicol In Vitro; 2015 Aug; 29(5):1156-65. PubMed ID: 25952326
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol-induced apoptosis is associated with activation of p53 and inhibition of protein translation in T47D human breast cancer cells.
Alkhalaf M
Pharmacology; 2007; 80(2-3):134-43. PubMed ID: 17534123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
